These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19694226)

  • 1. Alleviation of exogenous insulin requirement in type 1 diabetes mellitus after immunoablation and transplantation of autologous hematopoietic stem cells.
    Snarski E; Torosian T; Paluszewska M; Urbanowska E; Milczarczyk A; Jedynasty K; Franek E; Jedrzejczak WW
    Pol Arch Med Wewn; 2009 Jun; 119(6):422-6. PubMed ID: 19694226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I.
    Snarski E; Milczarczyk A; Torosian T; Paluszewska M; Urbanowska E; Król M; Boguradzki P; Jedynasty K; Franek E; Wiktor-Jedrzejczak W
    Bone Marrow Transplant; 2011 Apr; 46(4):562-6. PubMed ID: 20581881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
    Voltarelli JC; Couri CE; Stracieri AB; Oliveira MC; Moraes DA; Pieroni F; Coutinho M; Malmegrim KC; Foss-Freitas MC; Simões BP; Foss MC; Squiers E; Burt RK
    JAMA; 2007 Apr; 297(14):1568-76. PubMed ID: 17426276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous hematopoietic stem cell transplantation in type 1-diabetes.
    Rosengren AH; Renström E
    Islets; 2009; 1(1):81-3. PubMed ID: 21084854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of immunoablation and hematopoietic cell transplantation in the treatment of early diabetes type 1.
    Snarski E; Milczarczyk A; Franek E; Jedrzejczak W
    Ann Transplant; 2010; 15(3):75-9. PubMed ID: 20877271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis.
    D'Addio F; Valderrama Vasquez A; Ben Nasr M; Franek E; Zhu D; Li L; Ning G; Snarski E; Fiorina P
    Diabetes; 2014 Sep; 63(9):3041-6. PubMed ID: 24947362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stopping diabetes in its tracks: autologous non-myeloablative stem cell transplantation.
    Fousteri G; Hayek A; von Herrath M
    Regen Med; 2007 Sep; 2(5):845-51. PubMed ID: 17907936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes.
    Gu W; Hu J; Wang W; Li L; Tang W; Sun S; Cui W; Ye L; Zhang Y; Hong J; Zhu D; Ning G
    Diabetes Care; 2012 Jul; 35(7):1413-9. PubMed ID: 22723579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapy for type 1 diabetes: autologous hematopoietic stem cell transplantation.
    Li L; Gu W; Zhu D
    J Diabetes; 2012 Dec; 4(4):332-7. PubMed ID: 23190701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Insulin Independence in Type 1 Diabetes Mellitus Using a Simplified Autologous Stem Cell Transplant.
    Cantú-Rodríguez OG; Lavalle-González F; Herrera-Rojas MÁ; Jaime-Pérez JC; Hawing-Zárate JÁ; Gutiérrez-Aguirre CH; Mancias-Guerra C; González-Llano O; Zapata-Garrido A; Villarreal-Pérez JZ; Gómez-Almaguer D
    J Clin Endocrinol Metab; 2016 May; 101(5):2141-8. PubMed ID: 26859103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for prolonged remission after autologous hematopoietic stem cell transplantation in young patients with type 1 diabetes mellitus.
    Xiang H; Chen H; Li F; Liu J; Su Y; Hao L; Wang F; Wang Z; Zeng Q
    Cytotherapy; 2015 Nov; 17(11):1638-45. PubMed ID: 26318272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations.
    Snarski E; Milczarczyk A; Hałaburda K; Torosian T; Paluszewska M; Urbanowska E; Król M; Boguradzki P; Jedynasty K; Franek E; Wiktor-Jedrzejczak W
    Bone Marrow Transplant; 2016 Mar; 51(3):398-402. PubMed ID: 26642342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autologous peripheral blood hematopoietic stem cell transplantation in the treatment of type 1 diabetic mellitus: a report of 16 cases].
    Feng K; Xu YW; Ye FG; Xiao L; Ma XH; Gao Y; Zhang X; Yao SZ; Shi BY
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(28):1966-9. PubMed ID: 22093891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.
    Hommes DW; Duijvestein M; Zelinkova Z; Stokkers PC; Ley MH; Stoker J; Voermans C; van Oers MH; Kersten MJ
    J Crohns Colitis; 2011 Dec; 5(6):543-9. PubMed ID: 22115372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.
    Thakkar UG; Trivedi HL; Vanikar AV; Dave SD
    Cytotherapy; 2015 Jul; 17(7):940-7. PubMed ID: 25869301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus.
    Lisukov IA; Sizikova SA; Kulagin AD; Kruchkova IV; Gilevich AV; Konenkova LP; Zonova EV; Chernykh ER; Leplina OY; Sentyakova TN; Demin AA; Kozlov VA
    Lupus; 2004; 13(2):89-94. PubMed ID: 14995000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease.
    Rabusin M; Andolina M; Maximova N; Lepore L; Parco S; Tuveri G; Jankovic G
    Haematologica; 2000 Nov; 85(11 Suppl):81-5. PubMed ID: 11268330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up.
    Gu Y; Gong C; Peng X; Wei L; Su C; Qin M; Wang X; Li F
    Chin Med J (Engl); 2014; 127(14):2618-22. PubMed ID: 25043077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for high-dose cyclophosphamide and medium-dose total body irradiation in the conditioning of children with progressive systemic and polyarticular juvenile chronic arthritis before autologous stem cell transplantation.
    Vossen JM; Brinkman DM; Bakker B; Hoogerbrugge PM; ten Cate R
    Rheumatology (Oxford); 1999 Aug; 38(8):762-3. PubMed ID: 10501429
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of persistent remission following initial recovery in patients with type 1 diabetes treated with autologous peripheral blood stem cell transplantation.
    Walicka M; Milczarczyk A; Snarski E; Jedynasty K; Halaburda K; Torosian T; Urbanowska E; Król M; Jędrzejczak WW; Franek E
    Diabetes Res Clin Pract; 2018 Sep; 143():357-363. PubMed ID: 30036612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.